lobbying_activities: 2883103

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2883103	982b67de-2c71-4b01-8af6-0d5549e217fe	Q3	CATHOLIC HEALTH ASSOCIATION OF THE UNITED STATES	8497	CATHOLIC HEALTH ASSOCIATION OF THE UNITED STATES	2022	third_quarter	TOB	Urged Congress to continue to reject efforts to weaken the FDAs authority over tobacco products and any such efforts during consideration of the FY 2023 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations bill. Expressed support for the FDAs proposed rule to reduce the nicotine level in cigarettes to non-addictive or minimally addictive levels. Such a standard would generate massive public health benefits, preventing millions of young people from smoking and dramatically reducing the number of people who die from tobacco-caused diseases. Urged Congress to continue to reject efforts to weaken the FDAs authority over tobacco products and any such efforts during consideration of the FY 2023 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations bill. Urged congress to prioritize the development of bipartisan, bicameral legislation that would give FDAs Center for Tobacco Products the authority to regulate synthetic nicotine products as tobacco products and to quickly enact it into law.	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE		189724	0	0	2022-10-20T09:14:37-04:00